X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2855) 2855
Publication (166) 166
Book Review (69) 69
Book Chapter (46) 46
Magazine Article (5) 5
Book / eBook (2) 2
Conference Proceeding (2) 2
Dissertation (2) 2
Newsletter (2) 2
Transcript (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1700) 1700
humans (1528) 1528
direct oral anticoagulants (1154) 1154
anticoagulants (1050) 1050
warfarin (978) 978
dabigatran (883) 883
rivaroxaban (813) 813
direct thrombin inhibitor (757) 757
venous thromboembolism (747) 747
atrial fibrillation (702) 702
hematology (679) 679
administration, oral (616) 616
anticoagulants - therapeutic use (613) 613
peripheral vascular disease (555) 555
male (519) 519
apixaban (480) 480
female (465) 465
anticoagulants - administration & dosage (451) 451
stroke (447) 447
thromboembolism (436) 436
atrial-fibrillation (434) 434
anticoagulants - adverse effects (431) 431
dabigatran etexilate (429) 429
cardiac & cardiovascular systems (402) 402
pharmacology & pharmacy (398) 398
aged (386) 386
prevention (383) 383
anticoagulation (330) 330
thrombin (322) 322
thrombosis (319) 319
risk factors (298) 298
middle aged (297) 297
atrial fibrillation - drug therapy (284) 284
direct oral anticoagulant (284) 284
bleeding (281) 281
pharmacokinetics (274) 274
hemorrhage - chemically induced (272) 272
management (272) 272
safety (266) 266
treatment outcome (262) 262
medicine & public health (253) 253
medicine, general & internal (252) 252
stroke prevention (247) 247
molecular-weight heparin (244) 244
direct thrombin inhibitors (233) 233
blood coagulation - drug effects (232) 232
stroke - prevention & control (229) 229
therapy (226) 226
analysis (225) 225
factor xa inhibitors (225) 225
risk (225) 225
surgery (221) 221
patients (218) 218
factor xa inhibitor (215) 215
anticoagulants - pharmacology (214) 214
antithrombotic therapy (214) 214
factor-xa inhibitor (206) 206
pharmacodynamics (206) 206
deep-vein thrombosis (205) 205
oral anticoagulants (204) 204
adult (199) 199
atrial fibrillation - complications (196) 196
heparin (195) 195
care and treatment (194) 194
edoxaban (194) 194
aged, 80 and over (193) 193
double-blind (180) 180
cardiology (176) 176
nonvalvular atrial-fibrillation (174) 174
hemorrhage (173) 173
drug therapy (171) 171
prothrombin complex concentrate (169) 169
animals (167) 167
cardiac arrhythmia (164) 164
abridged index medicus (156) 156
vitamin k - antagonists & inhibitors (150) 150
thrombin - antagonists & inhibitors (149) 149
venous thromboembolism - drug therapy (149) 149
enoxaparin (148) 148
internal medicine (148) 148
clinical trials (147) 147
beta-alanine - analogs & derivatives (143) 143
warfarin - therapeutic use (142) 142
health aspects (141) 141
anticoagulants - pharmacokinetics (140) 140
ximelagatran (140) 140
reversal (138) 138
pulmonary embolism (136) 136
coagulation (133) 133
mortality (133) 133
efficacy (131) 131
vitamin k antagonists (130) 130
stroke - etiology (129) 129
medical research (128) 128
review (128) 128
thromboembolism - prevention & control (126) 126
dosage and administration (124) 124
retrospective studies (124) 124
benzimidazoles - therapeutic use (121) 121
fibrillation (121) 121
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2658) 2658
German (88) 88
French (68) 68
Spanish (45) 45
Japanese (34) 34
Russian (25) 25
Hungarian (7) 7
Czech (4) 4
Italian (4) 4
Polish (4) 4
Dutch (2) 2
Arabic (1) 1
Chinese (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 64, Issue 11, pp. 1128 - 1139
Abstract Background Non–vitamin K oral anticoagulants (NOACs) do not require routine laboratory monitoring. However, laboratory measurement may be desirable in... 
Cardiovascular | Internal Medicine | dabigatran | rivaroxaban | monitoring | laboratory | apixaban | MEASURING RIVAROXABAN | CARDIAC & CARDIOVASCULAR SYSTEMS | DIRECT THROMBIN INHIBITOR | DABIGATRAN CONCENTRATIONS | PROTHROMBIN TIME | PARTIAL THROMBOPLASTIN TIME | COAGULATION ASSAYS | IN-VITRO | FACTOR-XA INHIBITOR | PLASMA-CONCENTRATIONS | INTERNATIONAL NORMALIZED RATIO | Anticoagulants - administration & dosage | Humans | Antithrombins - administration & dosage | Thiophenes - administration & dosage | Dabigatran | Factor Xa Inhibitors - administration & dosage | Antithrombins - pharmacology | Pyridones - administration & dosage | Rivaroxaban | Benzimidazoles - administration & dosage | beta-Alanine - pharmacology | Factor Xa Inhibitors - pharmacology | beta-Alanine - analogs & derivatives | Pyrazoles - pharmacology | Administration, Oral | Morpholines - administration & dosage | beta-Alanine - administration & dosage | Morpholines - pharmacology | Thiophenes - pharmacology | Pyrazoles - administration & dosage | Partial Thromboplastin Time | Anticoagulants - pharmacology | Benzimidazoles - pharmacology | Drug Monitoring | Pyridones - pharmacology | Measurement | Anticoagulants (Medicine) | Vitamins | Studies | Anticoagulants | Plasma | Bibliographic literature | Laboratories | Drug therapy | Drug dosages | Bone surgery
Journal Article
Journal Article
Blood, ISSN 0006-4971, 01/2010, Volume 115, Issue 1, pp. 15 - 20
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 06/2010, Volume 103, Issue 6, pp. 1116 - 1127
Journal Article
Journal of Clinical Pharmacy and Therapeutics, ISSN 0269-4727, 04/2017, Volume 42, Issue 2, pp. 132 - 134
Journal Article
Gut, ISSN 0017-5749, 03/2016, Volume 65, Issue 3, pp. 374 - 389
Journal Article